Aki Iguchi

This inventor holds 8 USPTO granted patents and 6 published patent applications and 10 EPO patents. Top assignee: Arkray, Inc.. Active years: 2014-2016.

USPTO Granted Patents = 8 (Patent Applications = 6)

% Patents Active = 100.0

EPO Patents = 10 (Patent Applications = 13)

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

8 out of 567

Arkray, Inc.

patents

Years Active: 2014-2016

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9359647 - Probe for detection of polymorphism in EGFR gene, amplification primer, and use thereof (2016-06-07),

2. 9169518 - Primer set for detecting EGFR exon 21 polymorphism and application thereof (2015-10-27),

3. 9115391 - Method of detecting a polymorphism at a polymorphism site (2015-08-25),

4. 9096894 - Dry reagent, dry reagent kit, reagent container, and method for producing dry reagent (2015-08-04),

5. 9045799 - Probe for detecting polymorphism in CYP3A gene, method of detecting polymorphism, method of evaluating drug efficacy, and reagent kit for detecting polymorphism (2015-06-02),

6. 8748590 - Oligonucleotides for detection test of polymorphism of EGFR exon 19 and use therof (2014-06-10),

7. 8624018 - Probe, polymorphism detection method, method of evaluating drug efficacy or tolerance, and reagent kit (2014-01-07),

8. 8624017 - Probe, polymorphism detection method, method of evaluating drug efficacy or tolerance, disease prediction method and reagent kit (2014-01-07),

Title: Aki Iguchi: Innovator in Genetic Detection Technologies

Introduction

Aki Iguchi is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of genetic detection technologies, holding a total of 8 patents. His work focuses on developing innovative methods for detecting polymorphisms in genes, particularly the EGFR gene, which is crucial in cancer research and treatment.

Latest Patents

Iguchi's latest patents include a probe for the detection of polymorphism in the EGFR gene and an amplification primer for this purpose. The polymorphism-detecting probe and amplification primer enable simple and highly reliable determination of different polymorphisms in the EGFR gene. Another notable invention is a primer set for detecting the EGFR exon 21 polymorphism, specifically the L858R variant. This primer set consists of a P1 oligonucleotide and a P2 oligonucleotide, designed to perform amplification using a specific region of the gene as a template. The P1 oligonucleotide has cytosine as a base complementary to the 172792nd base of SEQ ID NO: 1, while the P2 oligonucleotide has adenine. The melting temperature of the P1 oligonucleotide is higher than that of the P2 oligonucleotide, and the P1 oligonucleotide is longer than the P2 oligonucleotide. Additionally, Iguchi's inventions include a polymorphism detection method using the primer set, a method for evaluating EGFR tyrosine kinase inhibitors, and a kit that includes the primer set.

Career Highlights

Aki Iguchi is currently employed at Arkray, Inc., where he continues to innovate in the field of genetic testing. His work has been instrumental in advancing the understanding of genetic variations and their implications in medical science.

Collaborations

Iguchi collaborates with notable colleagues, including Mitsuharu Hirai and Mariko Komori, who contribute to his research and development efforts.

Conclusion

Aki Iguchi's contributions to genetic detection technologies have made a significant impact in the field of medical research. His innovative patents and ongoing work at Arkray, Inc. continue to pave the way for advancements in understanding genetic polymorphisms and their applications in healthcare.